BiotechTube
Sequentia Biotech

Sequentia Biotech

Barcelona, Spain· Est.
sequentiabiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Sequentia Biotech is a Barcelona-based bioinformatics service and software provider that empowers organizations to unlock the value of multiomics data. The company operates a hybrid business model, combining fee-for-service consulting and sequencing with its proprietary, no-code software platforms (Sequentia Hub, BatchX) and a suite of specialized analytical solutions for microbiome, genomics, and transcriptomics. With a focus on enabling clients in over 65 countries, Sequentia positions itself as a critical partner for R&D and clinical diagnostics, bridging the gap between complex data generation and interpretable biological knowledge.

Infectious DiseaseGastrointestinalMicrobiome-Related Disorders

Technology Platform

Proprietary bioinformatics software ecosystem including Sequentia Hub (connected solutions environment) and BatchX (no-code bioinformatics pipeline platform), powered by specialized analytical engines for metagenomics (GAIA®, MICK® suite), transcriptomics (AIR®), and outbreak surveillance (PROKY™).

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The rapid adoption of multiomics in pharma R&D and clinical diagnostics creates strong demand for both expert consulting and scalable, no-code analysis platforms.
The global focus on microbiome health and pathogen surveillance opens large markets in diagnostics, agriculture, and food safety where Sequentia's specialized solutions are directly applicable.

Risk Factors

Faces intense competition from both large life science tools corporations and numerous bioinformatics startups.
Rapid technological evolution requires constant R&D investment to avoid obsolescence.
Commercializing clinical diagnostics software involves navigating complex regulatory and reimbursement pathways beyond initial CE marking.

Competitive Landscape

Competes with bioinformatics service providers (e.g., contract research organizations), standalone bioinformatics software companies (e.g., DNAnexus, Partek), and the in-house solutions of large sequencing/platform companies (e.g., Illumina, Qiagen). Differentiation lies in its combination of deep consulting expertise, a no-code platform (BatchX), and a focused suite of CE-IVD marked clinical microbiome tools.

More companies in AI / Machine Learning →More companies in Spain →